MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0043916
Prowill Pharmaceuticals Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.03 Cr
▼ 49% YoY
Net profit · FY 2025
₹95,749
Net margin 0.2%
EBITDA · FY 2025
₹33.78 Lakh
EBITDA margin 5.6%
Authorised capital
₹5.16 Cr
Registered with MCA
Paid-up capital
₹4.75 Cr
Issued & subscribed
Company age
14 yrs
Est. 2012
Employees · EPFO
9
Provident fund records
Directors on board
2
As per MCA filings
About Prowill Pharmaceuticals Private Limited
Data last updated:
Prowill Pharmaceuticals Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2012PTC229057. Its GSTIN is 27AAGCP5279D1Z8 (Maharashtra).
The company has an authorised share capital of ₹5.16 Cr and a paid-up capital of ₹4.75 Cr. It is led by directors Santosh Shrikrishna Joshi and Varsha Santosh Joshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Navi Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.03 Cr, a decline of 49% compared to the previous year. For the same year it recorded a net profit of ₹95,749 (net margin 0.2%) and EBITDA of ₹33.78 Lakh (EBITDA margin 5.6%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 18% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
Court records list 7 cases involving the company, including 7 filed against it.
Prowill Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0043916). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website prowillpharmaceuticals.com.
Company details
CIN U74999MH2012PTC229057
Registration Number 229057
Incorporation Date 30 March 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0043916
Recognitions & Rankings of Prowill Pharmaceuticals
Contact details
Prowill Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is prowillpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressJ. P. House Plot No. D – – 28/16 M.I.D.C. T.T.C. Industrial Area Turbhe Navi Mum, Bai, Navi Mumbai, Maharashtra, India – 400705
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Prowill Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Prowill Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Prowill Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Prowill Pharmaceuticals Private Limited, buy the company report.
Financials of Prowill Pharmaceuticals Private Limited
FY 2025 filings availableProwill Pharmaceuticals Private Limited reported revenue of ₹6.03 Cr (down 49% YoY) for FY 2025.
Revenue · FY 2025
₹6.03 Cr ▼ 49%
Net profit · FY 2025
₹95,749 margin 0.2%
EBITDA · FY 2025
₹33.78 Lakh margin 5.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 49%
3 years · compounded
▼ 20%
5 years · compounded
▼ 18%
EBITDA CAGR growth
1 year
▲ 36%
3 years · compounded
▼ 23%
5 years · compounded
▼ 15%
Revenue has declined at a compounded annual rate (CAGR) of 18% over five years, including a 49% fall in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.78 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹95,749 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Prowill Pharmaceuticals Private Limited, buy the company report.
Board of directors of Prowill Pharmaceuticals Private Limited
Prowill Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Shrikrishna Joshi | Director | 17 Jul 2020 | 6 Years 3 Months | Current |
| Varsha Santosh Joshi Also directs: Allcure Health Care Private Limited | Director | 18 Jul 2022 | 4 Years 3 Months | Current |
Auditor
Prowill Pharmaceuticals Private Limited is audited by Bipin Kothari and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Bipin Kothari and Associates | FY 2023 | 155037 |
Shareholding
The shareholding of Prowill Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Prowill Pharmaceuticals Private Limited, buy the company report.
Legal cases
Prowill Pharmaceuticals Private Limited has 7 court cases on record: 7 filed against it. All cases are disposed.
Total cases
7
Filed against the company
7
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 7 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (Other Misc.Cri.Appln) | Filed against the company by Radcom Packaging Pvt. Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Ss cases s) | Filed against the company by Sneha Medicare Pvt Ltd. | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Radcom Packaging Pvt. Ltd. | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Ms Pacific Organics Pvt Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Ss cases SW) | Filed against the company by an individual | Disposed |
To see the full case history of Prowill Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prowill Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Prowill Pharmaceuticals Private Limited has a workforce of 9 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
Employee count
9
Active EPFO establishments
1
Employee growth
-25%
GST
Prowill Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCP5279D1Z8 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Prowill Pharmaceuticals Private Limited, buy the company report.
Recent activity
Prowill Pharmaceuticals Private Limited has 8 board changes on record since 2017: 2 appointments and 6 cessations. The latest: Varsha Santosh Joshi ceased to be Additional Director on 30 Sep 2022.
AGM
Prowill Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Prowill Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Varsha Santosh Joshi ceased to be Additional Director.
Appointed
Varsha Santosh Joshi was appointed as Director.
Ceased
Santosh Shrikrishna Joshi ceased to be Additional Director.
Appointed
Santosh Shrikrishna Joshi was appointed as Director.
Ceased
Suhas Ramesh Ghuge ceased to be Director.
Ceased
Rasika Sanjay Patwardhan ceased to be Director.
Ceased
Dagadu Ganpat Bansode ceased to be Additional Director.
Ceased
Deepak Tulshiram Patil ceased to be Additional Director.
Incorporation
30 Mar 2012
Prowill Pharmaceuticals Private Limited was registered on 30 Mar 2012 with Roc Mumbai & aged 14 years 6 months as per MCA records.
Frequently asked questions
Prowill Pharmaceuticals is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 March 2012 (14+ years old) and is registered under CIN U74999MH2012PTC229057.
Prowill Pharmaceuticals has 2 current directors:
- Santosh Shrikrishna Joshi - Director
- Varsha Santosh Joshi - Director
The latest financial statements of Prowill Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Prowill Pharmaceuticals is 27AAGCP5279D1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of Prowill Pharmaceuticals is U74999MH2012PTC229057. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prowill Pharmaceuticals has 7 court cases on record: 7 filed against it.
Prowill Pharmaceuticals was incorporated on 30 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Varsha Santosh Joshi ceased to be Additional Director on 30 Sep 2022. Varsha Santosh Joshi was appointed as Director on 18 Jul 2022. Santosh Shrikrishna Joshi ceased to be Additional Director on 31 Dec 2020. Prowill Pharmaceuticals has 8 board changes on record in total.
Yes, Prowill Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0043916).
Prowill Pharmaceuticals can be reached through the website prowillpharmaceuticals.com. Its registered office is in Navi Mumbai, Maharashtra, India.